Q1 EPS Estimate for iTeos Therapeutics Boosted by Analyst
iTeos Therapeutics, Inc. (NASDAQ:ITOS – Free Report) – Analysts at HC Wainwright boosted their Q1 2025 earnings estimates for shares of iTeos Therapeutics in a report issued on Thursday, March 6th. HC Wainwright analyst S. Ramakanth now expects that the company will earn ($1.39) per share for the quarter, up from their previous estimate of […]
